Skip to main content

Table 4 Distribution of studied patients with multiple sclerosis at Kasr Alainy Multiple Sclerosis Unit, Cairo, Egypt 2019–2020 according to adequacy of intake of energy and macronutrients among the study groups pre- and post-intervention

From: Impact of nutrition counseling on anthropometry and dietary intake of multiple sclerosis patients at Kasr Alainy Multiple Sclerosis Unit, Cairo, Egypt 2019–2020: randomized controlled clinical trial

Compared intake with RDA##

Pre-intervention

Post-intervention

P value #

IG (N = 60)

CG (N = 60)

IG (N = 57)

CG (N = 56)

N

%

N

%

N

%

N

%

Calories

Unsafe

4

6.7

8

13.3

4

7.0

4

7.1

0.015*

Unacceptable

14

23.3

11

18.3

10

17.5

15

26.8

Acceptable

26

43.3

27

45.0

38

66.7

22

39.3

Overconsumption

16

26.7

14

23.3

5

8.8

15

26.8

Carbohydrate

Unsafe

11

18.3

10

16.7

7

12.3

11

19.6

0.051

Unacceptable

17

28.3

10

16.7

10

17.5

10

17.9

Acceptable

15

25.0

26

43.3

36

63.2

23

41.1

Overconsumption

17

28.3

14

23.3

4

7.0

12

21.4

Fat

Unsafe

8

13.3

10

16.7

6

10.5

8

14.3

0.002*

Unacceptable

9

15.0

12

20.0

8

14.0

12

21.4

Acceptable

22

36.7

21

35.0

37

64.9

17

30.4

Overconsumption

21

35.0

17

28.3

6

10.5

19

33.9

Protein

Unsafe

1

1.7

1

1.7

0

0.0

0

0.0

0.091

Unacceptable

3

5.0

1

1.7

0

0.0

4

7.1

Acceptable

6

10.0

14

23.3

10

17.5

6

10.7

Overconsumption

50

83.3

44

73.3

47

82.5

46

82.1

  1. # P value: Pearson chi-square test for carbohydrate and fat, Fisher’s Exact test for calories and proteins
  2. ##Unsafe < 50%, Unacceptable 5050—75%, Acceptable 7575—120%, Overconsumption ≥ 120% of RDA
  3. *Significant P value